{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T22:29:40Z","timestamp":1725056980419},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2012,12,23]],"date-time":"2012-12-23T00:00:00Z","timestamp":1356220800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1007\/s00296-012-2620-0","type":"journal-article","created":{"date-parts":[[2012,12,22]],"date-time":"2012-12-22T04:17:32Z","timestamp":1356149852000},"page":"3059-3063","source":"Crossref","is-referenced-by-count":3,"title":["Tc-99\u00a0m diethylenetriamine-pentaacetic acid (DTPA): is it reliable for assessment of methotrexate-induced cumulative effect on renal filtration in rheumatoid arthritis patients?"],"prefix":"10.1007","volume":"33","author":[{"given":"Amr","family":"Amin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dina","family":"Effat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nabila","family":"Goher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Basma","family":"Ramadan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,12,23]]},"reference":[{"key":"2620_CR1","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/j.1756-185X.2010.01562.x","volume":"13","author":"E Capkin","year":"2010","unstructured":"Capkin E, Cakirbay H, Karkucak M et al (2010) Prevalence of rheumatoid arthritis in the eastern Black Sea region of Turkey. Int J Rheum Dis 13:380\u2013384","journal-title":"Int J Rheum Dis"},{"key":"2620_CR2","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1093\/rheumatology\/kem370","volume":"47","author":"S Karie","year":"2008","unstructured":"Karie S, Gandjbakhch F, Janus N et al (2008) Kidney disease in RA patients: prevalence and implications on RA related drug management: the MATRIX study. Rheumatol (Oxford) 47:350\u2013354","journal-title":"Rheumatol (Oxford)"},{"key":"2620_CR3","first-page":"525","volume-title":"Current rheumatology diagnosis and treatment","author":"J Imboden","year":"2007","unstructured":"Imboden J (2007) Medications. In: Imboden J, HellMann D, Stone J (eds) Current rheumatology diagnosis and treatment, 2nd edn. The McGraw-Hill Companies, Inc, USA, pp 525\u2013528","edition":"2"},{"key":"2620_CR4","unstructured":"Weinblatt ME (2001) Methotrexate. In: Ruddy S, Harris ED, Sledge CB (eds) Kelley\u2019s textbook of rheumatology, 6th edn. WB. Saunders Company, Philadelphia, pp 843, 846\u2013849"},{"issue":"Suppl 35","key":"2620_CR5","first-page":"S83","volume":"22","author":"R Rau","year":"2004","unstructured":"Rau R, Herborn G (2004) Benefit and risk of methotrexate treatment in rheumatoid arthritis. Clin Exp Rheumatol 22(Suppl 35):S83\u2013S94","journal-title":"Clin Exp Rheumatol"},{"key":"2620_CR6","first-page":"1126","volume":"20","author":"P Seideman","year":"1993","unstructured":"Seideman P, M\u00fcller-Suur R, Ekman E (1993) Renal effects of low dose methotrexate in rheumatoid arthritis. J Rheumatol 20:1126\u20131128","journal-title":"J Rheumatol"},{"key":"2620_CR7","first-page":"169","volume":"37","author":"C Chantler","year":"1969","unstructured":"Chantler C, Garnett ES, Parsons V et al (1969) Glomerular filtration rate measurement in man by the single injection methods using 51Cr-EDTA. Clin Sci 37:169\u2013180","journal-title":"Clin Sci"},{"key":"2620_CR8","first-page":"969","volume":"3","author":"K Harris","year":"2007","unstructured":"Harris K, Stribling B (2007) Automated estimated GFR reporting: a new tool to promote safer prescribing in patients with chronic kidney disease? Ther Clin Risk Manag 3:969\u2013972","journal-title":"Ther Clin Risk Manag"},{"key":"2620_CR9","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/S0272-6386(12)81022-5","volume":"16","author":"RD Perrone","year":"1990","unstructured":"Perrone RD, Steinman TI, Beck GJ et al (1990) Utility of radioisotopic filtration markers in chronic renal insufficiency: simultaneous comparison of 125I-iothalamate, 169Yb-DTPA, 99mTc-DTPA, and inulin. The modification of diet in renal disease study. Am J Kidney Dis 16:224\u2013235","journal-title":"Am J Kidney Dis"},{"key":"2620_CR10","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1093\/rheumatology\/keg023","volume":"42","author":"EJ Kingdon","year":"2003","unstructured":"Kingdon EJ, Knight CJ, Dustan K et al (2003) Calculated glomerular filtration rate is a useful screening tool to identify scleroderma patients with renal impairment. Rheumatol (Oxford) 42:26\u201333","journal-title":"Rheumatol (Oxford)"},{"key":"2620_CR11","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1093\/rheumatology\/35.5.403","volume":"35","author":"ME Weinblatt","year":"1996","unstructured":"Weinblatt ME (1996) Methotrexate in rheumatoid arthritis: toxicity issues. Br J Rheumatol 35:403\u2013405","journal-title":"Br J Rheumatol"},{"key":"2620_CR12","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","volume":"31","author":"FC Arnett","year":"1988","unstructured":"Arnett FC, Edworthy SM, Bloch DA et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthr Rheum 31:315\u2013324","journal-title":"Arthr Rheum"},{"key":"2620_CR13","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/art.1780380107","volume":"38","author":"ML Prevoo","year":"1995","unstructured":"Prevoo ML, van\u2019t Hof MA, Kuper HH et al (1995) Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthr Rheum 38:44\u201348","journal-title":"Arthr Rheum"},{"key":"2620_CR14","doi-asserted-by":"crossref","first-page":"565","DOI":"10.2214\/ajr.138.3.565","volume":"138","author":"GF Gates","year":"1982","unstructured":"Gates GF (1982) Glomerular filtration rate: estimation from fractional renal accumulation of 99mTc-DTPA (stannous). AJR Am J Roentgenol 138:565\u2013570","journal-title":"AJR Am J Roentgenol"},{"key":"2620_CR15","doi-asserted-by":"crossref","unstructured":"National Kidney Foundation Kidney Disease, Outcome Quality Initiative Advisory Board (2002) Clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification. Kidney disease quality initiative: Staging system and action planes for chronic kidney disease. Am J of kidney disease, 39 (suppl 2):SI\u2013246","DOI":"10.1053\/ajkd.2002.30952"},{"key":"2620_CR16","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1080\/00365510802141140","volume":"241","author":"J Coresh","year":"2008","unstructured":"Coresh J, Auguste P (2008) Reliability of GFR formulas based on serum creatinine, with special reference to the MDRD Study equation. Scand J Clin Lab Invest Suppl 241:30\u201338","journal-title":"Scand J Clin Lab Invest Suppl"},{"key":"2620_CR17","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/s10067-010-1389-3","volume":"29","author":"RH Mohamed","year":"2010","unstructured":"Mohamed RH, Zayed HS, Amin A (2010) Renal disease in systemic sclerosis with normal serum creatinine. Clin Rheumatol 29:729\u2013737","journal-title":"Clin Rheumatol"},{"key":"2620_CR18","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1475-097X.2009.00910.x","volume":"30","author":"H Gutte","year":"2010","unstructured":"Gutte H, M\u00f8ller ML, Pfeifer AK et al (2010) Estimating GFR in children with 99mTc-DTPA renography: a comparison with single-sample 51Cr-EDTA clearance. Clin Physiol Funct Imaging 30:169\u2013174","journal-title":"Clin Physiol Funct Imaging"},{"key":"2620_CR19","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1136\/ard.2008.106617","volume":"69","author":"SM Verstappen","year":"2010","unstructured":"Verstappen SM, Bakker MF, Heurkens AH et al (2010) Utrecht Rheumatoid Arthritis Cohort Study Group. Adverse events and factors associated with toxicity in patients with early rheumatoid arthritis treated with methotrexate tight control therapy: the CAMERA study. Ann Rheum Dis 69:1044\u20131048","journal-title":"Ann Rheum Dis"},{"key":"2620_CR20","first-page":"46","volume-title":"Hypertension primer","author":"RR Townsend","year":"2008","unstructured":"Townsend RR (2008) Blood pressure raising effects of anti inflammatory drugs, angiogenesis inhibitors, and cholesterol-ester-transfer protein inhibitors. In: Izzo JL, Sica DA, Black HR (eds) Hypertension primer, 4th edn. Lippincott, William and Wilkins, USA, p 46","edition":"4"},{"key":"2620_CR21","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1517\/14740330903311023","volume":"8","author":"S Harirforoosh","year":"2009","unstructured":"Harirforoosh S, Jamali F (2009) Renal adverse effects of nonsteroidal anti-inflammatory drugs. Expert Opin Drug Saf 8:669\u2013681","journal-title":"Expert Opin Drug Saf"},{"key":"2620_CR22","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/(SICI)1099-081X(199804)19:3<163::AID-BDD82>3.0.CO;2-L","volume":"19","author":"MP Iqbal","year":"1998","unstructured":"Iqbal MP, Baig JA, Ali AA et al (1998) The effects of non-steroidal anti-inflammatory drugs on the disposition of methotrexate in patients with rheumatoid arthritis. Biopharm Drug Dispos 19:163\u2013167","journal-title":"Biopharm Drug Dispos"},{"key":"2620_CR23","unstructured":"Fitzgerald GA, Patrono C (2005) The coxibs; selective inhibitors of cyclooxygenase-2. N Engl J Med 345:433\u2013442. In: Cush JJ, Kavanaugh A, Stein CM (eds) Rheumatology diagnosis and therapeutics, 2nd edn. Lippincott Williams and Wilkins, USA, p 494"},{"key":"2620_CR24","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1136\/ard.2008.105049","volume":"69","author":"D Daoussis","year":"2010","unstructured":"Daoussis D, Panoulas VF, Antonopoulos I et al (2010) Cardiovascular risk factors and not disease activity, severity or therapy associate with renal dysfunction in patients with rheumatoid arthritis. Ann Rheum Dis 69:517\u2013521","journal-title":"Ann Rheum Dis"},{"key":"2620_CR25","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1681\/ASN.2006030204","volume":"17","author":"K Amann","year":"2006","unstructured":"Amann K, Wanner C, Ritz E (2006) Cross-talk between the kidney and the cardiovascular system. J Am Soc Nephrol 17:2112\u20132119","journal-title":"J Am Soc Nephrol"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-012-2620-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-012-2620-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-012-2620-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T07:21:43Z","timestamp":1559028103000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-012-2620-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12,23]]},"references-count":25,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["2620"],"URL":"https:\/\/doi.org\/10.1007\/s00296-012-2620-0","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12,23]]}}}